ScienceDex / Researcher record
Marcus Aaron Horwitz
- University of California, Los Angeles · Internal Medicine (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,264,553 | 3 | #4,322 |
| 2025 | $1,924,671 | 3 | #7,157 |
| 2026 | $1,128,421 | 2 | #17,831 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected3 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1865892Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
FY2025 award records by amount
NIH award records listing Marcus Aaron Horwitz as a PI. Multi-PI records show the full award amount for context.
- 5R01AI183978-02R01Contact PIEfficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infectionUniversity of California, Los Angeles · Internal Medicine (NIH department code)$931.8Kaward amount
- 5R01AI148122-05R01Contact PIDevelopment of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearanceUniversity of California, Los Angeles · Internal Medicine (NIH department code)$756.6Kaward amount
- 1R21AI185484-01A1R21Contact PIIdentification by High Throughput Screening of Inhibitors of the Mycobacterium tuberculosis ESX-1 and ESX-5 Type VII Secretion Systems – critical virulence determinants and novel drug targetsUniversity of California, Los Angeles · Internal Medicine (NIH department code)$236.3Kaward amount
Award organization
Organizations that administered FY2025 awards listing Marcus Aaron Horwitz as a PI.
FY2025 award administered by University of California, Los Angeles (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, Los Angeles
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4322
- 2024Entered Top 25% NationallyRanked #4322
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Marcus Aaron Horwitz.